Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 164

1.

Experimental Study of Body-Fin Interaction and Vortex Dynamics Generated by a Two Degree-Of-Freedom Fish Model.

Brooks SA, Green MA.

Biomimetics (Basel). 2019 Oct 8;4(4). pii: E67. doi: 10.3390/biomimetics4040067.

2.

Erratum: Author Correction: Improved reference genome for the domestic horse increases assembly contiguity and composition.

Kalbfleisch TS, Rice ES, DePriest MS Jr, Walenz BP, Hestand MS, Vermeesch JR, O'Connell BL, Fiddes IT, Vershinina AO, Saremi NF, Petersen JL, Finno CJ, Bellone RR, McCue ME, Brooks SA, Bailey E, Orlando L, Green RE, Miller DC, Antczak DF, MacLeod JN.

Commun Biol. 2019 Sep 11;2:342. doi: 10.1038/s42003-019-0591-3. eCollection 2019.

3.

Correction: Mutations in MITF and PAX3 Cause "Splashed White" and Other White Spotting Phenotypes in Horses.

Hauswirth R, Haase B, Blatter M, Brooks SA, Burger D, Drögemüller C, Gerber V, Henke D, Janda J, Jude R, Magdesian KG, Matthews JM, Poncet PA, Svansson V, Tozaki T, Wilkinson-White L, Penedo MCT, Rieder S, Leeb T.

PLoS Genet. 2019 Aug 2;15(8):e1008321. doi: 10.1371/journal.pgen.1008321. eCollection 2019 Aug.

4.

Molecular Detection of Severe Combined Immunodeficiency Disorder in Arabian Horses in Egypt.

AbouEl Ela NA, El-Nesr KA, Ahmed HA, Brooks SA.

J Equine Vet Sci. 2018 Sep;68:55-58. doi: 10.1016/j.jevs.2018.05.210. Epub 2018 May 26.

PMID:
31256889
5.

Upregulation of endogenous thrombopoietin receptor (MPL) with in vivo passage of calreticulin (CALR) mutant Ba/F3 cells, highlighting MPL as the requisite cytokine receptor for CALR mediated transformation.

Brooks SA, Kim DM, Morse SJ, Nguyen QH, Craver BM, Lai HY, Fleischman AG.

Leuk Res. 2019 Jul;82:11-14. doi: 10.1016/j.leukres.2019.05.003. Epub 2019 May 9. No abstract available.

PMID:
31128484
6.

Community Treatment Orders and Other Forms of Mandatory Outpatient Treatment.

O'Reilly RL, Hastings T, Chaimowitz GA, Neilson GE, Brooks SA, Freeland A.

Can J Psychiatry. 2019 May;64(5):356-374. doi: 10.1177/0706743719845906.

7.

A candidate gene approach identifies variants in SLC45A2 that explain dilute phenotypes, pearl and sunshine, in compound heterozygote horses.

Holl HM, Pflug KM, Yates KM, Hoefs-Martin K, Shepard C, Cook DG, Lafayette C, Brooks SA.

Anim Genet. 2019 Jun;50(3):271-274. doi: 10.1111/age.12790. Epub 2019 Apr 21.

PMID:
31006892
8.

Response to: "Concern Regarding the Publication by Posbergh et al".

Posbergh CJ, Pollott GE, Southard TL, Divers TJ, Brooks SA.

J Equine Vet Sci. 2019 Jan;72:124-125. doi: 10.1016/j.jevs.2018.10.022. Epub 2018 Oct 30. No abstract available.

PMID:
30929776
9.

Genome-wide association study of equine herpesvirus type 1-induced myeloencephalopathy identifies a significant single nucleotide polymorphism in a platelet-related gene.

Brosnahan MM, Al Abri MA, Brooks SA, Antczak DF, Osterrieder N.

Vet J. 2019 Mar;245:49-54. doi: 10.1016/j.tvjl.2018.12.013. Epub 2018 Dec 12.

PMID:
30819425
10.

Detecting ovarian cancer using extracellular vesicles: progress and possibilities.

Carollo E, Paris B, Samuel P, Pantazi P, Bartelli TF, Dias-Neto E, Brooks SA, Pink RC, Carter DRF.

Biochem Soc Trans. 2019 Feb 28;47(1):295-304. doi: 10.1042/BST20180286. Epub 2019 Jan 30. Review.

PMID:
30700499
11.

Defective negative regulation of Toll-like receptor signaling leads to excessive TNF-α in myeloproliferative neoplasm.

Lai HY, Brooks SA, Craver BM, Morse SJ, Nguyen TK, Haghighi N, Garbati MR, Fleischman AG.

Blood Adv. 2019 Jan 22;3(2):122-131. doi: 10.1182/bloodadvances.2018026450.

12.

Whole-genome sequencing reveals a large deletion in the MITF gene in horses with white spotted coat colour and increased risk of deafness.

Henkel J, Lafayette C, Brooks SA, Martin K, Patterson-Rosa L, Cook D, Jagannathan V, Leeb T.

Anim Genet. 2019 Apr;50(2):172-174. doi: 10.1111/age.12762. Epub 2019 Jan 15.

PMID:
30644113
13.

TBX3 and ASIP genotypes reveal discrepancies in officially recorded coat colors of Hucul horses.

Mackowski M, Wodas L, Brooks SA, Cieslak J.

Animal. 2019 Sep;13(9):1811-1816. doi: 10.1017/S1751731118003506. Epub 2019 Jan 7.

PMID:
30614426
14.

Improved reference genome for the domestic horse increases assembly contiguity and composition.

Kalbfleisch TS, Rice ES, DePriest MS Jr, Walenz BP, Hestand MS, Vermeesch JR, O Connell BL, Fiddes IT, Vershinina AO, Saremi NF, Petersen JL, Finno CJ, Bellone RR, McCue ME, Brooks SA, Bailey E, Orlando L, Green RE, Miller DC, Antczak DF, MacLeod JN.

Commun Biol. 2018 Nov 16;1:197. doi: 10.1038/s42003-018-0199-z. eCollection 2018. Erratum in: Commun Biol. 2019 Sep 11;2:342.

15.

Identification of loci affecting sexually dimorphic patterns for height and recurrent laryngeal neuropathy risk in American Belgian Draft Horses.

Brooks SA, Stick J, Braman A, Palermo K, Robinson NE, Ainsworth DM.

Physiol Genomics. 2018 Dec 1;50(12):1051-1058. doi: 10.1152/physiolgenomics.00068.2018. Epub 2018 Sep 28.

PMID:
30265593
16.

Binding of aberrant glycoproteins recognizable by Helix pomatia agglutinin in adrenal cancers.

Parameswaran R, Tan WB, Nga ME, Soon GST, Ngiam KY, Brooks SA, Sadler GP, Mihai R.

BJS Open. 2018 Apr 27;2(5):353-359. doi: 10.1002/bjs5.70. eCollection 2018 Sep.

17.

Population genomics and morphometric assignment of western honey bees (Apis mellifera L.) in the Republic of South Africa.

Eimanifar A, Brooks SA, Bustamante T, Ellis JD.

BMC Genomics. 2018 Aug 15;19(1):615. doi: 10.1186/s12864-018-4998-x.

18.

Use of principle component analysis to quantitatively score the equine metabolic syndrome phenotype in an Arabian horse population.

Lewis SL, Holl HM, Long MT, Mallicote MF, Brooks SA.

PLoS One. 2018 Jul 12;13(7):e0200583. doi: 10.1371/journal.pone.0200583. eCollection 2018.

19.

Integrative radiomics expression predicts molecular subtypes of primary clear cell renal cell carcinoma.

Yin Q, Hung SC, Rathmell WK, Shen L, Wang L, Lin W, Fielding JR, Khandani AH, Woods ME, Milowsky MI, Brooks SA, Wallen EM, Shen D.

Clin Radiol. 2018 Sep;73(9):782-791. doi: 10.1016/j.crad.2018.04.009. Epub 2018 May 23.

20.

Construction of two whole genome radiation hybrid panels for dromedary (Camelus dromedarius): 5000RAD and 15000RAD.

Perelman PL, Pichler R, Gaggl A, Larkin DM, Raudsepp T, Alshanbari F, Holl HM, Brooks SA, Burger PA, Periasamy K.

Sci Rep. 2018 Jan 31;8(1):1982. doi: 10.1038/s41598-018-20223-5.

21.

Cisplatin induces the release of extracellular vesicles from ovarian cancer cells that can induce invasiveness and drug resistance in bystander cells.

Samuel P, Mulcahy LA, Furlong F, McCarthy HO, Brooks SA, Fabbri M, Pink RC, Carter DRF.

Philos Trans R Soc Lond B Biol Sci. 2018 Jan 5;373(1737). pii: 20170065. doi: 10.1098/rstb.2017.0065.

22.

Single nucleotide polymorphisms for DNA typing in the domestic horse.

Holl HM, Vanhnasy J, Everts RE, Hoefs-Martin K, Cook D, Brooks SA, Carpenter ML, Bustamante CD, Lafayette C.

Anim Genet. 2017 Dec;48(6):669-676. doi: 10.1111/age.12608. Epub 2017 Sep 13.

PMID:
28901559
23.

Cadmium inhibits placental trophoblast cell migration via miRNA regulation of the transforming growth factor beta (TGF-β) pathway.

Brooks SA, Fry RC.

Food Chem Toxicol. 2017 Nov;109(Pt 1):721-726. doi: 10.1016/j.fct.2017.07.059. Epub 2017 Aug 1.

24.

Developing a 670k genotyping array to tag ~2M SNPs across 24 horse breeds.

Schaefer RJ, Schubert M, Bailey E, Bannasch DL, Barrey E, Bar-Gal GK, Brem G, Brooks SA, Distl O, Fries R, Finno CJ, Gerber V, Haase B, Jagannathan V, Kalbfleisch T, Leeb T, Lindgren G, Lopes MS, Mach N, da Câmara Machado A, MacLeod JN, McCoy A, Metzger J, Penedo C, Polani S, Rieder S, Tammen I, Tetens J, Thaller G, Verini-Supplizi A, Wade CM, Wallner B, Orlando L, Mickelson JR, McCue ME.

BMC Genomics. 2017 Jul 27;18(1):565. doi: 10.1186/s12864-017-3943-8.

25.

Computationally optimized deimmunization libraries yield highly mutated enzymes with low immunogenicity and enhanced activity.

Salvat RS, Verma D, Parker AS, Kirsch JR, Brooks SA, Bailey-Kellogg C, Griswold KE.

Proc Natl Acad Sci U S A. 2017 Jun 27;114(26):E5085-E5093. doi: 10.1073/pnas.1621233114. Epub 2017 Jun 12.

26.

Whole genome sequencing reveals a novel deletion variant in the KIT gene in horses with white spotted coat colour phenotypes.

Dürig N, Jude R, Holl H, Brooks SA, Lafayette C, Jagannathan V, Leeb T.

Anim Genet. 2017 Aug;48(4):483-485. doi: 10.1111/age.12556. Epub 2017 Apr 26.

PMID:
28444912
27.

Application of Genomic Estimation Methods of Inbreeding and Population Structure in an Arabian Horse Herd.

Al Abri MA, König von Borstel U, Strecker V, Brooks SA.

J Hered. 2017 Jun 1;108(4):361-368. doi: 10.1093/jhered/esx025.

PMID:
28444202
28.

Genomewide association study reveals a risk locus for equine metabolic syndrome in the Arabian horse.

Lewis SL, Holl HM, Streeter C, Posbergh C, Schanbacher BJ, Place NJ, Mallicote MF, Long MT, Brooks SA.

J Anim Sci. 2017 Mar;95(3):1071-1079. doi: 10.2527/jas.2016.1221.

PMID:
28380523
29.

A novel splice mutation within equine KIT and the W15 allele in the homozygous state lead to all white coat color phenotypes.

Holl HM, Brooks SA, Carpenter ML, Bustamante CD, Lafayette C.

Anim Genet. 2017 Aug;48(4):497-498. doi: 10.1111/age.12554. Epub 2017 Apr 5. No abstract available.

PMID:
28378922
30.

Associations between Tumor Vascularity, Vascular Endothelial Growth Factor Expression and PET/MRI Radiomic Signatures in Primary Clear-Cell-Renal-Cell-Carcinoma: Proof-of-Concept Study.

Yin Q, Hung SC, Wang L, Lin W, Fielding JR, Rathmell WK, Khandani AH, Woods ME, Milowsky MI, Brooks SA, Wallen EM, Shen D.

Sci Rep. 2017 Mar 3;7:43356. doi: 10.1038/srep43356.

31.

Isolation of Viable Glycosylation-Specific Cell Populations for Further In Vitro or In Vivo Analysis Using Lectin-Coated Magnetic Beads.

Beaman EM, Carter DR, Brooks SA.

Methods Mol Biol. 2017;1560:109-119. doi: 10.1007/978-1-4939-6788-9_7.

PMID:
28155148
32.

Lectin Histochemistry: Historical Perspectives, State of the Art, and the Future.

Brooks SA.

Methods Mol Biol. 2017;1560:93-107. doi: 10.1007/978-1-4939-6788-9_6. Review.

PMID:
28155147
33.

Polymorphism at expressed DQ and DR loci in five common equine MHC haplotypes.

Miller D, Tallmadge RL, Binns M, Zhu B, Mohamoud YA, Ahmed A, Brooks SA, Antczak DF.

Immunogenetics. 2017 Mar;69(3):145-156. doi: 10.1007/s00251-016-0964-4. Epub 2016 Nov 26.

34.

miRNAs as common regulators of the transforming growth factor (TGF)-β pathway in the preeclamptic placenta and cadmium-treated trophoblasts: Links between the environment, the epigenome and preeclampsia.

Brooks SA, Martin E, Smeester L, Grace MR, Boggess K, Fry RC.

Food Chem Toxicol. 2016 Dec;98(Pt A):50-57. doi: 10.1016/j.fct.2016.06.023. Epub 2016 Jun 29.

35.

Breast cancer osteomimicry and its role in bone specific metastasis; an integrative, systematic review of preclinical evidence.

Awolaran O, Brooks SA, Lavender V.

Breast. 2016 Dec;30:156-171. doi: 10.1016/j.breast.2016.09.017. Epub 2016 Oct 14. Review.

PMID:
27750106
36.

Loci impacting polymorphic gait in the Tennessee Walking Horse.

Staiger EA, Abri MA, Silva CA, Brooks SA.

J Anim Sci. 2016 Apr;94(4):1377-86. doi: 10.2527/jas.2015-9936.

PMID:
27135997
37.

Host genetic influence on papillomavirus-induced tumors in the horse.

Staiger EA, Tseng CT, Miller D, Cassano JM, Nasir L, Garrick D, Brooks SA, Antczak DF.

Int J Cancer. 2016 Aug 15;139(4):784-92. doi: 10.1002/ijc.30120. Epub 2016 May 6.

38.

N-acetylgalactosamine glycans function in cancer cell adhesion to endothelial cells: A role for truncated O-glycans in metastatic mechanisms.

Bapu D, Runions J, Kadhim M, Brooks SA.

Cancer Lett. 2016 Jun 1;375(2):367-374. doi: 10.1016/j.canlet.2016.03.019. Epub 2016 Mar 16.

PMID:
26994652
39.

Genome-wide association mapping of heritable temperament variation in the Tennessee Walking Horse.

Staiger EA, Albright JD, Brooks SA.

Genes Brain Behav. 2016 Jun;15(5):514-26. doi: 10.1111/gbb.12290. Epub 2016 May 5.

40.

Skeletal variation in Tennessee Walking Horses maps to the LCORL/NCAPG gene region.

Staiger EA, Al Abri MA, Pflug KM, Kalla SE, Ainsworth DM, Miller D, Raudsepp T, Sutter NB, Brooks SA.

Physiol Genomics. 2016 May;48(5):325-35. doi: 10.1152/physiolgenomics.00100.2015. Epub 2016 Mar 1.

PMID:
26931356
41.

The MC1R and ASIP Coat Color Loci May Impact Behavior in the Horse.

Jacobs LN, Staiger EA, Albright JD, Brooks SA.

J Hered. 2016 May;107(3):214-9. doi: 10.1093/jhered/esw007. Epub 2016 Feb 16. Erratum in: J Hered. 2016 Sep;107(5):479.

42.

Alternate Metabolic Programs Define Regional Variation of Relevant Biological Features in Renal Cell Carcinoma Progression.

Brooks SA, Khandani AH, Fielding JR, Lin W, Sills T, Lee Y, Arreola A, Milowsky MI, Wallen EM, Woods ME, Smith AB, Nielsen ME, Parker JS, Lalush DS, Rathmell WK.

Clin Cancer Res. 2016 Jun 15;22(12):2950-9. doi: 10.1158/1078-0432.CCR-15-2115. Epub 2016 Jan 19.

43.

Variant in the RFWD3 gene associated with PATN1, a modifier of leopard complex spotting.

Holl HM, Brooks SA, Archer S, Brown K, Malvick J, Penedo MC, Bellone RR.

Anim Genet. 2016 Feb;47(1):91-101. doi: 10.1111/age.12375. Epub 2015 Nov 16.

PMID:
26568529
44.

miRNAs and ovarian cancer: a miRiad of mechanisms to induce cisplatin drug resistance.

Samuel P, Pink RC, Brooks SA, Carter DR.

Expert Rev Anticancer Ther. 2016;16(1):57-70. doi: 10.1586/14737140.2016.1121107. Epub 2015 Dec 5. Review.

PMID:
26567444
45.

Patients with ClearCode34-identified molecular subtypes of clear cell renal cell carcinoma represent unique populations with distinct comorbidities.

Haake SM, Brooks SA, Welsh E, Fulp WJ, Chen DT, Dhillon J, Haura E, Sexton W, Spiess PE, Pow-Sang J, Rathmell WK, Fishman M.

Urol Oncol. 2016 Mar;34(3):122.e1-7. doi: 10.1016/j.urolonc.2015.09.015. Epub 2015 Nov 3.

46.

JAK2(V617I) results in cytokine hypersensitivity without causing an overt myeloproliferative disorder in a mouse transduction-transplantation model.

Brooks SA, Luty SB, Lai HY, Morse SJ, Nguyen TK, Royer LR, Agarwal A, Druker BJ, Fleischman AG.

Exp Hematol. 2016 Jan;44(1):24-9.e1. doi: 10.1016/j.exphem.2015.09.006. Epub 2015 Oct 13.

47.

Generation of a de novo transcriptome from equine lamellar tissue.

Holl HM, Gao S, Fei Z, Andrews C, Brooks SA.

BMC Genomics. 2015 Oct 3;16:739. doi: 10.1186/s12864-015-1948-8.

48.

Over-expression of miR-31 or loss of KCNMA1 leads to increased cisplatin resistance in ovarian cancer cells.

Samuel P, Pink RC, Caley DP, Currie JM, Brooks SA, Carter DR.

Tumour Biol. 2016 Feb;37(2):2565-73. doi: 10.1007/s13277-015-4081-z. Epub 2015 Sep 19.

PMID:
26386726
49.

NPM1 mutation is associated with leukemia cutis in acute myeloid leukemia with monocytic features.

Luskin MR, Huen AO, Brooks SA, Stewart C, Watt CD, Morrissette JJ, Lieberman DB, Bagg A, Rosenbach M, Perl AE.

Haematologica. 2015 Oct;100(10):e412-4. doi: 10.3324/haematol.2015.129346. Epub 2015 Jun 25. No abstract available.

50.

Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead.

Goodson WH 3rd, Lowe L, Carpenter DO, Gilbertson M, Manaf Ali A, Lopez de Cerain Salsamendi A, Lasfar A, Carnero A, Azqueta A, Amedei A, Charles AK, Collins AR, Ward A, Salzberg AC, Colacci A, Olsen AK, Berg A, Barclay BJ, Zhou BP, Blanco-Aparicio C, Baglole CJ, Dong C, Mondello C, Hsu CW, Naus CC, Yedjou C, Curran CS, Laird DW, Koch DC, Carlin DJ, Felsher DW, Roy D, Brown DG, Ratovitski E, Ryan EP, Corsini E, Rojas E, Moon EY, Laconi E, Marongiu F, Al-Mulla F, Chiaradonna F, Darroudi F, Martin FL, Van Schooten FJ, Goldberg GS, Wagemaker G, Nangami GN, Calaf GM, Williams G, Wolf GT, Koppen G, Brunborg G, Lyerly HK, Krishnan H, Ab Hamid H, Yasaei H, Sone H, Kondoh H, Salem HK, Hsu HY, Park HH, Koturbash I, Miousse IR, Scovassi AI, Klaunig JE, Vondráček J, Raju J, Roman J, Wise JP Sr, Whitfield JR, Woodrick J, Christopher JA, Ochieng J, Martinez-Leal JF, Weisz J, Kravchenko J, Sun J, Prudhomme KR, Narayanan KB, Cohen-Solal KA, Moorwood K, Gonzalez L, Soucek L, Jian L, D'Abronzo LS, Lin LT, Li L, Gulliver L, McCawley LJ, Memeo L, Vermeulen L, Leyns L, Zhang L, Valverde M, Khatami M, Romano MF, Chapellier M, Williams MA, Wade M, Manjili MH, Lleonart ME, Xia M, Gonzalez MJ, Karamouzis MV, Kirsch-Volders M, Vaccari M, Kuemmerle NB, Singh N, Cruickshanks N, Kleinstreuer N, van Larebeke N, Ahmed N, Ogunkua O, Krishnakumar PK, Vadgama P, Marignani PA, Ghosh PM, Ostrosky-Wegman P, Thompson PA, Dent P, Heneberg P, Darbre P, Sing Leung P, Nangia-Makker P, Cheng QS, Robey RB, Al-Temaimi R, Roy R, Andrade-Vieira R, Sinha RK, Mehta R, Vento R, Di Fiore R, Ponce-Cusi R, Dornetshuber-Fleiss R, Nahta R, Castellino RC, Palorini R, Abd Hamid R, Langie SA, Eltom SE, Brooks SA, Ryeom S, Wise SS, Bay SN, Harris SA, Papagerakis S, Romano S, Pavanello S, Eriksson S, Forte S, Casey SC, Luanpitpong S, Lee TJ, Otsuki T, Chen T, Massfelder T, Sanderson T, Guarnieri T, Hultman T, Dormoy V, Odero-Marah V, Sabbisetti V, Maguer-Satta V, Rathmell WK, Engström W, Decker WK, Bisson WH, Rojanasakul Y, Luqmani Y, Chen Z, Hu Z.

Carcinogenesis. 2015 Jun;36 Suppl 1:S254-96. doi: 10.1093/carcin/bgv039. Review. Erratum in: Carcinogenesis. 2016 Mar;37(3):344.

Supplemental Content

Loading ...
Support Center